> As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review. So kind of them, but isn't the review supposed to be d

> As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review. So kind of them, but isn't the review supposed to be done before the vaccine is released on the general population? As written it seems the review is dependent on more data from experimental subjects.